MedTrace Logo

Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers

NCT02427360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1022

Last updated 2018-11-26

No results posted yet for this study

Summary

This is a retrospective non randomized cohort to evaluate efficacy of MAS3 on patients with uncomplicated P. falciparum malaria or mixed infection (P. falciparum + a non-falciparum species). The review of patients' records and blood samples will be performed for patients treated at the clinics of Shoklo Malaria Research Unit from the period of January 2003 to December 2013.

Conditions

  • P. Falciparum Malaria
  • P. Falciparum Malaria Mixed Infection

Sponsors & Collaborators

  • Texas Biomedical Research Institute

    collaborator UNKNOWN

  • Nanyang Technological University

    collaborator OTHER

  • University of Oxford

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02427360 on ClinicalTrials.gov